Gynecologic imaging reporting and data system combined with three-dimensional contrast-enhanced ultrasonography for differential diagnosis of benign and malignant ovarian masses
2018-06-25,,,3,,,
, , ,3, , ,
(1.Department of Ultrasound, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou 363000, China; 2.Department of Clinical Medicine, Quanzhou Medical College, Quanzhou 362000, China; 3.Department of Ultrasound, the Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, China)
早期诊断卵巢癌是提高患者5年生存率的关键[1]。多项研究[2-3]已证实,通过妇科超声影像报告和数据系统(gynecologic imaging reporting and data system, GI-RADS)及三维超声造影(3D contrast enhanced ultrasound, 3D-CEUS)均可有效鉴别良恶性卵巢肿块。本研究旨在探讨GI-RADS及3D-CEUS联合应用在鉴别卵巢良恶性肿块中的价值。
1 资料与方法
1.1 一般资料 选取2015年7月—2016年7月期间于我院门诊及住院治疗的102例卵巢肿块患者,年龄16~68岁,平均(32.8±12.2)岁。纳入标准:①经常规二维超声发现卵巢占位,病灶表现为囊实性或实性肿块,或表现为壁厚、分隔及壁上可见乳头状突起的囊性肿块;②接受二维超声联合3D-CEUS检查;③获得手术病理或临床最终随访诊断结果。排除标准:①妊娠及哺乳期女性;②严重心脏病患者;③超声造影剂过敏。患者对本研究所有检查均知情同意。
1.2 仪器与方法 采用GE Voluson E8三维彩色超声显像仪,RIC5-9-D超宽阴道探头(频率5.0~9.0 MHz)及RAB2-5-D腹部探头(频率2.0~5.0 MHz)。造影剂为SonoVue(Bracco公司)。首先行二维超声扫查,观察卵巢肿块有无大乳头状突起物(≥7 mm)、有无中心性血流、是否合并腹腔积液,并测量病灶内分隔或囊壁的厚度、血流阻力指数(resistance index, RI)及病灶实性成分比例。而后行3D-CEUS,将造影剂加入5 ml生理盐水后,经患者肘静脉一次性团注2.5 ml,再尾随注入5 ml生理盐水,切换至静态3D-CEUS模式,机械指数(mechanical index, MI)为0.08。开启断层超声成像(tomography ultrasound imaging, TUI)模式,每10 s采集1次图像并储存。
1.3 图像分析 由1名高年资超声医师对卵巢肿瘤患者二维超声及增强早期(20~70 s)超声造影图像进行评估[4],再由另1名年资相当的医师独立评估图像。
采用GI-RADS评估方法对卵巢肿块进行分类。GI-RADS恶性指征[5]:①有大乳头状突起物(≥7 mm);……
杂志排行
中国医学影像技术的其它文章
- CT morphological characteristics of plantar nerves and their significances in diabetic foot
- Quantitative analysis of dynamic contrast-enhanced MRI in distinguishing different grades of prostate cancer
- Gd-EOB-DTPA enhanced MRI in assessing whole liver and segmental liver function
- Consistency of different physicians in diagnosis of malignant breast lesions with breast CEUS predictive model: A multicenter study
- Stretched-exponential model of DWI in differentiating malignant and benign breast lesions
- Contrast-enhanced MRA in differential diagnosis of spinal cord vascular malformation and secondary vascular tortuosity caused by non vascular malformations on spinal cord
